Effects of a Novel Compound (AL 721) on HTLV-III Infectivity in Vitro

N Engl J Med. 1985 Nov 14;313(20):1289-90. doi: 10.1056/NEJM198511143132011.

Publication types

  • Letter

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy
  • Aged
  • Antiviral Agents / pharmacology*
  • Deltaretrovirus / drug effects*
  • Deltaretrovirus / pathogenicity
  • Drug Combinations / pharmacology
  • Glycerides / pharmacology*
  • Humans
  • Lymphocytes / microbiology
  • Phosphatidylcholines / pharmacology*
  • Phosphatidylethanolamines / pharmacology*
  • Reverse Transcriptase Inhibitors

Substances

  • Antiviral Agents
  • Drug Combinations
  • Glycerides
  • Phosphatidylcholines
  • Phosphatidylethanolamines
  • Reverse Transcriptase Inhibitors
  • neutral lipid, phosphatidylcholine, phosphatidylethanolamine drug combination